Breast cancer: issues in risk reduction, screening and surveillance, early identification and therapy planning.
From May 29 to June 5, 2003, the American Society of Clinical Oncology held its 39th Annual Meeting in Chicago, Illinois, U.S.A. The meeting was devoted to the presentation of advances in clinical sciences, diagnosis, prevention and management of malignant disorders, and brings together investigators, clinicians, policy makers and other professionals interested in the science and impact of cancer worldwide. As a continuation of the report focusing on colon cancer in the last issue of Drug News & Perspectives, this report will focus on breast cancer. .
Levin
Mark
M
Division of Hematology and Oncology, Lincoln Medical and Mental Health Center, 234 Eugenio Mario de Hostas Boulevard, Bronx, NY 10451, USA. MLevinmd@aol.com
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D011159:Population Surveillance; D012307:Risk Factors